￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Osimertinib changes cancer outcomes and bids farewell to chemotherapy side effects

2025-10-19 11:44:20

Check Details
Serpatinib Retevmo brings new treatment option to lung cancer patients

2025-10-19 11:44:20

Check Details
Erlotinib or gefitinib, which one should I choose?

2025-10-19 11:44:20

Check Details
Gefitinib combined with lenvatinib is a potential therapy for advanced HCC_ Kanghule

2025-10-19 11:44:20

Check Details
Entrectinib can significantly improve the response rate of lung cancer patients

2025-10-19 11:44:20

Check Details
Mobotinib is an oral therapy for the treatment of lung cancer with EGFR exon 20 insertion mutation

2025-10-19 11:44:20

Check Details
How effective is Rybrevant in treating non-small cell lung cancer? How long does it take to see the effect

2025-10-19 11:44:20

Check Details
How effective is Tepotinib? What are the precautions for using Tepotinib?

2025-10-19 11:44:20

Check Details
In-depth analysis of the efficacy of entrectinib

2025-10-19 11:44:20

Check Details
What are the approved indications of gefitinib? What is the correct usage and dosage of gefitinib?

2025-10-19 11:44:20

Check Details
How effective is aletinib in treating patients with ALK-positive non-small cell lung cancer?

2025-10-19 11:44:20

Check Details
Gefitinib, a powerful therapeutic drug for lung cancer, is analyzed in depth in this article

2025-10-19 11:44:20

Check Details
Category
相关知识